drugset / Trial / NCT02243683
Safety Study of Immune System Modulator for Autoimmune Diseases
Phase 1
Completed
18 enrolled
Artax Biopharma Inc
Centro de Biología Molecular Severo Ochoa, Spain (CBMSO) · collabORION Clinical Services · collabPackaging Coordinators Inc · collabSimbec Research · collab
RandomizedCrossoverDouble-blind
Summary
The purpose of this study is to determine the toxicity, tolerability and safety of single ascending doses of AX-024.HCl in healthy male subjects.
Timeline
- Start
- 2014-09
- Primary completion
- 2014-11
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AX-024 | Unknown | — | Oral |
Indications
No indication recorded.